XTX Topco Ltd - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$415,487
-39.5%
310,065
-19.2%
0.07%
-42.3%
Q2 2023$687,088
+54.5%
383,848
+193.4%
0.12%
+30.9%
Q4 2022$444,778
+101.3%
130,817
+222.7%
0.09%
+70.9%
Q3 2022$221,000
-5.2%
40,541
-21.4%
0.06%
-42.1%
Q2 2022$233,000
+119.8%
51,606
+257.7%
0.10%
+106.5%
Q1 2022$106,000
+26.2%
14,429
+10.6%
0.05%
-4.2%
Q4 2021$84,000
-11.6%
13,051
-19.8%
0.05%
+50.0%
Q3 2021$95,00016,2720.03%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders